CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Fernandez Ponce, Cecilia ^a   Dominguez Villar, Margarita ^a   Aguado, Enrique ^a   Garcia Cozar, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; CHEMOKINE RECEPTOR CCR7; CORE PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; LENTIVIRUS VECTOR; MEMBRANE PROTEIN; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN TIM 3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL STIMULATION; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LENTIVIRINAE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; GENETIC TRANSDUCTION; JURKAT CELL LINE; PROTEIN ANALYSIS; PROTEIN SYNTHESIS INHIBITION; CELL CULTURE; CELL LINE; CELL PROLIFERATION; HEPACIVIRUS; METABOLISM;

HEPATITIS C VIRUS;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; HEPACIVIRUS; HUMANS; INTERLEUKIN-10; VIRAL CORE PROTEINS;

EID: 84901924890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085191     Document Type: Article

References (124)

1. Dehesa-Violante M, Nunez-Nateras R (2007) Epidemiology of Hepatitis Virus B and C. Archives of Medical Research 38: 606-611. (Pubitemid 47008933)
2. Rustgi VK (2007) The epidemiology of hepatitis C infection in the United States. Journal of Gastroenterology 42: 513-521.
3. Freeman AJ, Marinos G, Ffrench RA, Lloyd AR (2001) Immunopathogenesis of hepatitis C virus infection. Immunol Cell Biol 79: 515-536. (Pubitemid 33070441)
4. Lauer GM, Kim AY (2006) Spontaneous resolution of chronic hepatitis C virus infection: are we missing something? Clin Infect Dis 42: 953-954.
5. Poynard T, Yuen MF, Ratziu V, Lai CL (2003) Viral hepatitis C. Lancet 362: 2095-2100. (Pubitemid 38035201)
6. Shoukry NH, Cawthon AG, Walker CM (2004) Cell-Mediated Immunity And The Outcome Of Hepatitis C Virus Infection. Annual Review of Microbiology 58: 391-424. (Pubitemid 39551992)
7. Koziel MJ (2005) Cellular immune responses against hepatitis C virus. Clin Infect Dis 41 Suppl 1: S25-31.
8. Aberle JH, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, et al. (2006) Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 36: 24-31. (Pubitemid 44360574)
9. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, et al. (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194: 1395-1406. (Pubitemid 33081515)
10. Schulze zur Wiesch J, Lauer GM, Day CL, Kim AY, Ouchi K, et al. (2005) Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 175: 3603-3613.
11. Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, et al. (2005) Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201: 1741-1752. (Pubitemid 41002893)
12. Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, et al. (2003) Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37: 1189-1198. (Pubitemid 36538697)
13. Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, et al. (2005) Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41: 1019-1028. (Pubitemid 40593910)
14. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, et al. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447-3458. (Pubitemid 35013196)
15. Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, et al. (2005) Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42: 828-837. (Pubitemid 41401120)
16. Rushbrook SM, Hoare M, Alexander GJ (2007) T-regulatory lymphocytes and chronic viral hepatitis. Expert Opin Biol Ther 7: 1689-1703. (Pubitemid 350157495)
17. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, et al. (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071. (Pubitemid 39425561)
18. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, et al. (2003) Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38: 1437-1448. (Pubitemid 37466970)
19. Bolacchi F, Sinistro A, Ciaprini C, Demin F, Capozzi M, et al. (2006) Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 144: 188-196.
20. Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, et al. (2005) Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection. J Virol 79: 7852-7859. (Pubitemid 40756820)
21. Dominguez-Villar M, Fernandez-Ponce C, Munoz-Suano A, Gomez E, Rodriguez-Iglesias M, et al. (2012) Up-regulation of FOXP3 and induction of suppressive function in CD4+ Jurkat T-cells expressing hepatitis C virus core protein. Clin Sci (Lond) 123: 15-27.
22. Manigold T, Racanelli V (2007) T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 7: 804-813. (Pubitemid 350152043)
23. Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, et al. (2010) Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin Sci (Lond) 119: 97-109.
24. Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A (2010) Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepatol 52: 315-321.
25. Claassen MAA, de Knegt RJ, Janssen HLA, Boonstra A (2011) Retention of CD4(+) CD25(+) FoxP3(+) Regulatory T Cells in the Liver after Therapy-Induced Hepatitis C Virus Eradication in Humans. Journal of Virology 85: 5323-5330.
26. Hall CHT, Kassel R, Tacke RS, Hahn YS (2010) HCV+ Hepatocytes Induce Human Regulatory CD4+ T Cells through the Production of TGF-β. PLoS ONE 5: e12154.
27. Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, et al. (2005) T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection. J Virol 79: 7860-7867. (Pubitemid 40756821)
28. Tseng CT, Klimpel GR (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195: 43-49.
29. Melen K, Fagerlund R, Nyqvist M, Keskinen P, Julkunen I (2004) Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs. J Med Virol 73: 536-547. (Pubitemid 38857203)
30. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, et al. (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102: 2992-2997. (Pubitemid 40299904)
31. Reed KE, Rice CM (2000) Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242: 55-84. (Pubitemid 29467521)
32. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM (2004) Structural biology of hepatitis C virus. Hepatology 39: 5-19. (Pubitemid 38461460)
33. Irshad M, Dhar I (2006) Hepatitis C virus core protein: an update on its molecular biology, cellular functions and clinical implications. Med Princ Pract 15: 405-416. (Pubitemid 44561624)
34. Tellinghuisen TL, Rice CM (2002) Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol 5: 419-427.
35. Koziel MJ (1999) Cytokines in viral hepatitis. Semin Liver Dis 19: 157-169.
36. Dominguez-Villar M, Munoz-Suano A, Anaya-Baz B, Aguilar S, Novalbos JP, et al. (2007) Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis. J Leukoc Biol 82: 1301-1310. (Pubitemid 350133528)
37. Sundstrom S, Ota S, Dimberg LY, Masucci MG, Bergqvist A (2005) Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses. J Virol 79: 2230-2239. (Pubitemid 40204580)
38. Dominguez-Villar M, Garcia-Cozar FJ, Chambers BJ (2012) The effects of hepatitis C virus core protein on functional responses in the NK cell line YTS. Scand J Immunol 75: 54-60.
39. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS (2000) Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 106: 1239-1249.
40. Doumba PP, Serti E, Boutsikou M, Konstadoulakis MM, Georgopoulou U, et al. (2013) Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake. Cell Mol Life Sci.
41. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, et al. (2002) Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 76: 600-608. (Pubitemid 34033359)
42. Kondo Y, Sung VM, Machida K, Liu M, Lai MM (2006) Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology.
43. Zignego AL, Giannini C, Monti M, Gragnani L (2007) Hepatitis C virus lymphotropism: lessons from a decade of studies. Digestive and Liver Disease 39: S38-S45. (Pubitemid 47528193)
44. Castillo I, Rodriguez-Inigo E, Bartolome J, de Lucas S, Ortiz-Movilla N, et al. (2005) Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 54: 682-685. (Pubitemid 40559255)
45. Goutagny N, Fatmi A, De Ledinghen V, Penin F, Couzigou P, et al. (2003) Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 187: 1951-1958. (Pubitemid 36724494)
46. Blackard JT, Smeaton L, Hiasa Y, Horiike N, Onji M, et al. (2005) Detection of Hepatitis C Virus (HCV) in Serum and Peripheral-Blood Mononuclear Cells from HCV-Monoinfected and HIV/HCV-Coinfected Persons. J Infect Dis 192: 258-265. (Pubitemid 40993395)
47. Laskus T, Operskalski EA, Radkowski M, Wilkinson J, Mack WJ, et al. (2007) Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis 195: 124-133. (Pubitemid 44958234)
48. el-Awady MK, Tabll AA, Redwan el RM, Youssef S, Omran MH, et al. (2005) Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry. World J Gastroenterol 11: 5203-5208.
49. Pal S, Sullivan DG, Kim S, Lai KK, Kae J, et al. (2006) Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 130: 1107-1116.
50. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J (1998) The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. J Infect Dis 178: 1189-1192. (Pubitemid 28452222)
51. Kondo Y, Ueno Y, Kakazu E, Kobayashi K, Shiina M, et al. (2010) Lymphotropic HCV strain can infect human primary naïve CD4+ cells and affect their proliferation and IFN-c secretion activity. J Gastroenterol 46: 232-241.
52. Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, et al. (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48: 1843-1850.
53. Yao ZQ, Eisen-Vandervelde A, Ray S, Hahn YS (2003) HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1. Virology 314: 271-282. (Pubitemid 37153316)
54. Falcon V, Acosta-Rivero N, Chinea G, de la Rosa MC, Menendez I, et al. (2003) Nuclear localization of nucleocapsid-like particles and HCV core protein in hepatocytes of a chronically HCV-infected patient. Biochem Biophys Res Commun 310: 54-58. (Pubitemid 37162761)
55. Falcon V, Acosta-Rivero N, Shibayama M, Chinea G, Gavilondo JV, et al. (2005) HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients. Biochem Biophys Res Commun 329: 1320-1328. (Pubitemid 40568714)
56. Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, et al. (2001) Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 75: 8240-8250. (Pubitemid 32743696)
57. Tsitoura P, Georgopoulou U, Petres S, Varaklioti A, Karafoulidou A, et al. (2007) Evidence for cellular uptake of recombinant hepatitis C virus non-enveloped capsid-like particles. FEBS Letters 581: 4049-4057. (Pubitemid 47225070)
58. Carabaich A, Ruvoletto M, Bernardinello E, Tono N, Cavalletto L, et al. (2005) Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage. J Med Virol 76: 55-60. (Pubitemid 40446455)
59. Serti E, Doumba PP, Thyphronitis G, Tsitoura P, Katsarou K, et al. (2011) Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase. Cell Mol Life Sci 68: 505-522.
60. Hiroishi K, Ito T, Imawari M (2008) Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence. J Gastroenterol Hepatol 23: 1473-1482.
61. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, et al. (2007) Foxp3-dependent programme of regulatory T-cell differentiation. Nature.
62. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341. (Pubitemid 40387475)
63. Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8: 457-462. (Pubitemid 46605910)
64. Campbell DJ, Ziegler SF (2007) FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 7: 305-310. (Pubitemid 46480960)
65. Venken K, Thewissen M, Hellings N, Somers V, Hensen K, et al. (2007) A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 322: 1-11. (Pubitemid 46560587)
66. Hayashi RJ, Loh DY, Kanagawa O, Wang F (1998) Differences between responses of naive and activated T cells to anergy induction. J Immunol 160: 33-38. (Pubitemid 28116712)
67. Huang CT, Huso DL, Lu Z, Wang T, Zhou G, et al. (2003) CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction. J Immunol 170: 3945-3953. (Pubitemid 36428154)
68. Andris F, Denanglaire S, de Mattia F, Urbain J, Leo O (2004) Naive T cells are resistant to anergy induction by anti-CD3 antibodies. J Immunol 173: 3201-3208. (Pubitemid 39142027)
69. Zhao B-B, Zheng S-J, Gong L-L, Wang Y, Chen C-F, et al. (2013) T Lymphocytes from Chronic HCV-Infected Patients Are Primed for Activation-Induced Apoptosis and Express Unique Pro-Apoptotic Gene Signature. PLoS ONE 8: e77008.
70. Bowen DG, Walker CM (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436: 946-952. (Pubitemid 41191670)
71. Christel Gremion AC (2005) Hepatitis C virus and the immune system: a concise review. Reviews in Medical Virology 15: 235-268.
72. Rehermann BMD (2007) Chronic Infections with Hepatotropic Viruses: Mechanisms of Impairment of Cellular Immune Responses. Semin Liver Dis: 152-160.
73. Kakumu S, Okumura A, Ishikawa T, Iwata K, Yano M, et al. (1997) Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 108: 138-143. (Pubitemid 27140341)
74. Piazzolla G, Tortorella C, Schiraldi O, Antonaci S (2000) Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha. J Clin Immunol 20: 54-61. (Pubitemid 30210107)
75. Kaplan DE, Ikeda F, Li Y, Nakamoto N, Ganesan S, et al. (2008) Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J Hepatol 48: 903-913.
76. MacDonald AJ, Duffy M, Brady MT, McKiernan S, Hall W, et al. (2002) CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 185: 720-727. (Pubitemid 34226199)
77. Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, et al. (2007) Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 81: 5882-5892. (Pubitemid 46847025)
78. Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, et al. (2007) Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. Journal of Hepatology 47: 316-324. (Pubitemid 47189607)
79. Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, et al. (2007) Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression. J Virol 81: 2545-2553. (Pubitemid 46447020)
80. Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, et al. (2009) PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119: 551-564.
81. Chen A, Gaddipati S, Hong Y, Volkman DJ, Peerschke EI, et al. (1994) Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol 153: 1430-1440. (Pubitemid 24251088)
82. Krishnadas DK, Li W, Kumar R, Tyrrell DL, Agrawal B (2010) HCV-core and NS3 antigens play disparate role in inducing regulatory or effector T cells in vivo: Implications for viral persistence or clearance. Vaccine 28: 2104-2114.
83. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, et al. (2001) Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 75: 5550-5558. (Pubitemid 32488148)
84. Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, et al. (2010) Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+T Cells Is Linked to Antigen Recognition and T Cell Differentiation. Plos Pathogens 6.
85. Billerbeck E, Nakamoto N, Seigel B, Blum HE, Chang KM, et al. (2009) Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection. J Gen Virol 90: 1692-1701.
86. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, et al. (2002) Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8: 379-385. (Pubitemid 34407033)
87. Lee S, Hammond T, Watson MW, Flexman JP, Cheng W, et al. (2010) Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy? Clin Exp Immunol 161: 118-126.
88. Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, et al. (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 5: e1000313.
89. Castello G, Scala S, Palmieri G, Curley SA, Izzo F (2010) HCV-related hepatocellular carcinoma: From chronic inflammation to cancer. Clin Immunol 134: 237-250.
90. Sturm N, Thelu MA, Camous X, Dimitrov G, Ramzan M, et al. (2010) Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis. J Hepatol 53: 25-35.
91. Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, et al. (2004) Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 127: 870-882. (Pubitemid 39208419)
92. Muhanna N, Doron S, Wald O, Horani A, Eid A, et al. (2008) Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis. Hepatology 48: 963-977.
93. Li S, Jones KL, Woollard DJ, Dromey J, Paukovics G, et al. (2007) Defining target antigens for CD25+FOXP3+IFN-[gamma]- regulatory T cells in chronic hepatitis C virus infection. Immunol Cell Biol 85: 197-204. (Pubitemid 46701422)
94. Pham TN, Michalak TI (2008) Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 14: 2789-2793.
95. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, et al. (2004) Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78: 5867-5874. (Pubitemid 38661674)
96. Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, et al. (2002) Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731. (Pubitemid 34722268)
97. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC (1997) Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25: 449-458.
98. Eckels DD, Tabatabail N, Bian TH, Wang H, Muheisen SS, et al. (1999) In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation. Hum Immunol 60: 187-199. (Pubitemid 29202505)
99. Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, et al. (1997) CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 159: 1012-1018. (Pubitemid 127484258)
100. Ferri S, Lalanne C, Lanzoni G, Bassi M, Asioli S, et al. (2011) Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. Digestive and Liver Disease 43: 807-813.
101. Soguero C, Joo M, Chianese-Bullock KA, Nguyen DT, Tung K, et al. (2002) Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model. J Virol 76: 9345-9354. (Pubitemid 34919892)
102. Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH (2001) CTLA-4 regulates induction of anergy in vivo. Immunity 14: 145-155. (Pubitemid 32206517)
103. Read S, Malmstrom V, Powrie F (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192: 295-302. (Pubitemid 30470312)
104. Engelhardt JJ, Sullivan TJ, Allison JP (2006) CTLA-4 Overexpression Inhibits T Cell Responses through a CD28-B7-Dependent Mechanism. J Immunol 177: 1052-1061. (Pubitemid 44036607)
105. Read S, Greenwald R, Izcue A, Robinson N, Mandelbrot D, et al. (2006) Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In Vivo. J Immunol 177: 4376-4383. (Pubitemid 44469766)
106. Radziewicz H, Dunham RM, Grakoui A (2009) PD-1 tempers Tregs in chronic HCV infection. J Clin Invest 119: 450-453.
107. Kared H, Fabre T, Bedard N, Bruneau J, Shoukry NH (2013) Galectin-9 and IL-21 Mediate Cross-regulation between Th17 and Treg Cells during Acute Hepatitis C. PLoS Pathog 9: e1003422.
108. Shen T, Zheng J, Liang H, Xu C, Chen X, et al. (2011) Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients. Virol J 8: 279.
109. Radziewicz H, Ibegbu CC, Hon H, Osborn MK, Obideen K, et al. (2008) Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol 82: 9808-9822.
110. Sakthivel P, Gereke M, Bruder D (2012) Therapeutic intervention in cancer and chronic viral infections: antibody mediated manipulation of PD-1/PD-L1 interaction. Rev Recent Clin Trials 7: 10-23.
111. Fuller MJ, Callendret B, Zhu B, Freeman GJ, Hasselschwert DL, et al. (2013) Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). Proc Natl Acad Sci USA 110: 15001-15006.
112. Oestreich KJ, Yoon H, Ahmed R, Boss JM (2008) NFATc1 regulates PD-1 expression upon T cell activation. J Immunol 181: 4832-4839.
113. Bergqvist A, Rice CM (2001) Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J Virol 75: 772-781. (Pubitemid 32037280)
114. Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, et al. (2009) Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4(+) and CD8(+) T Cells. Journal of Virology 83: 9122-9130.
115. Moorman JP, Wang JM, Zhang Y, Ji XJ, Ma CJ, et al. (2012) Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection. J Immunol 189: 755-766.
116. Ji XJ, Ma CJ, Wang JM, Wu XY, Niki T, et al. (2013) HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway. Eur J Immunol 43: 458-467.
117. Golden-Mason L, Burton JR, Jr., Castelblanco N, Klarquist J, Benlloch S, et al. (2006) Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 44: 1098-1109. (Pubitemid 44748361)
118. Quiroga JA, Llorente S, Castillo I, Rodriguez-Inigo E, Pardo M, et al. (2006) Cellular immune responses associated with occult hepatitis c virus infection of the liver. Journal of Virology 80: 10972-10979. (Pubitemid 44706538)
119. Lange C, Scholl M, Melms A, Bischof F (2011) CD62L(high) Treg cells with superior immunosuppressive properties accumulate within the CNS during remissions of EAE. Brain Behav Immun 25: 120-126.
120. Fu S, Yopp AC, Mao X, Chen D, Zhang N, et al. (2004) CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 4: 65-78. (Pubitemid 38155491)
121. Menning A, Hopken UE, Siegmund K, Lipp M, Hamann A, et al. (2007) Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur J Immunol 37: 1575-1583. (Pubitemid 46939492)
122. Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, et al. (2013) Regulatory T cells: recommendations to simplify the nomenclature. Nature Publishing Group 14: 307-308.
123. Ebinuma H, Nakamoto N, Li Y, Price DA, Gostick E, et al. (2008) Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol 82: 5043-5053. (Pubitemid 351657064)
124. Shevach EM (2002) CD4(+)CD25(+) suppressor T cells: More questions than answers [Review]. Nature Reviews Immunology 2: 389-400.